Facebook  Twitter  LinkedIn
+31 50 313 1905
 info@organ-assist.nl

dHOPE clinical trial

The purpose is to study the efficacy of end-ischemic dHOPE in reducing the incidence of NAS within six months after controlled DCD (Maastricht category III) liver transplantation. In this trial the donor livers will be perfused with an a-cellular solution (UW-MPS), at 10 - 12 degrees Celcius, just about two hours prior to the transplantation. The Liver Assist is the dedicated device for this trial.

The dHOPE trial is initiated by the University Medical Center Groningen (UMCG, The Netherlands). Other participating centers are: Erasmus MC (Rotterdam), UMC Leiden, the University Hospital of Leuven (Belgium) and the University Hospital of Ghent (Belgium).

More information about this trial can be found at the following websites:

ClinicalTrials.gov Identifier:  NCT02584283

UMCG hospital website

dhope centers

 

Home  
News and publications  
Products  
   Donor Assist
   Kidney Assist-transport 
   Lung Assist  
   Liver Assist  
   Kidney Assist  
             Our technology  
Publications
Organization  
Contact
            Bornholmstraat 84
9723 AZ Groningen
The Netherlands
+31 50 313 1905
info@organ-assist.nl

Facebook Twitter LinkedIn
 

CE certificateafbeeldingiag
ISO 13485 certificateCOPE websiteafbeelding

WHEN TIME COUNTS AND QUALITY SAVES LIVES
Improve your organ procurement, test the organs and increase the amount of transplantable organs.
We offer the tools for optimal pre-conditoning, preservation and re-conditioning.
Organ Assist has the solution for you.
header imgfotofotofotofotofoto
logo
white